Antecedents and correlates of methadone treatment entry: A comparison of out-of-treatment and in-treatment cohorts

Drug and Alcohol Dependence

Volumn 115, Issue 1-2, 2011, Pages 23-29

  Schwartz, Robert P ^a   Kelly, Sharon M ^a   O'Grady, Kevin E ^b   Mitchell, Shannon Gwin ^a   Brown, Barry S ^c  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

Author keywords

Heroin addiction; Methadone treatment; Outreach; Treatment entry

Indexed keywords

COCAINE; METHADONE; OPIATE;

ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIOR CHANGE; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; COPING BEHAVIOR; CRIMINAL BEHAVIOR; EMPLOYMENT STATUS; FAMILY RELATION; FEMALE; HEALTH PROGRAM; HELP SEEKING BEHAVIOR; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PAROLE; PREDICTION; PRIORITY JOURNAL; PROBATION; SOCIAL SUPPORT; TREATMENT INDICATION; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ADMISSION; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 79955548226     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.10.016     Document Type: Article

References (57)

1. Ball J.C., Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcomes 1991, Springer-Verlag, New York.
2. Bell J., Trinh L., Butler B., Randall D., Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction 2009, 104(7):1193-1200.
3. Boatler J.F., Knight K., Simpson D.D. Assessment of an AIDS intervention program during drug abuse treatment. J. Subst. Abuse Treat. 1994, 11(4):367-372.
4. Booth R., Koester S., Brewster J.T., Weibel W.W., Fritz R.B. Intravenous drug users and AIDS: risk behaviors. Am. J. Drug Alcohol Abuse 1991, 17(3):337-353.
5. Booth R.E., Corsi K.F., Mikulich S.K. Improving entry to methadone maintenance among out-of-treatment injection drug users. J. Subst. Abuse Treat. 2003, 24(4):305-311.
6. Brown B.S., Jansen D.R., Benn G.J. Changes in attitude toward methadone. Arch. Gen. Psychiatry 1975, 32(2):214-218.
7. Brown B.S., Needle R. Modifying the process of treatment to meet the threat of AIDS. Int. J. Addict. 1994, 29:1739-1752.
8. Brown B.S., O'Grady K.E., Battjes R.J., Katz E.C. The community assessment inventory - client views of supports to drug abuse treatment. J. Subst. Abuse Treat. 2004, 27:241-251.
9. Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100(7):981-989.
10. Calsyn D.A., DeMarco F.J., Saxon A.J., Sloan K.L., Gibbon K.E. Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment. AJPH 2003, 93(7):1086-1088.
11. Camacho L.M., Brown B.S., Simpson D.D. Psychological dysfunction and HIV/AIDS risk behavior. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 11(2):198-202.
12. Celentano D.D., Munoz A., Cohn S., Vlahov D. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug Alcohol Depend. 2001, 61(3):315-322.
13. Center for Substance Abuse Treatment (CSAT) Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939 2004, Substance Abuse and Mental Health Services Administration, Rockville, MD.
14. Center for Substance Abuse Treatment (CSAT) Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048 2005, Substance Abuse and Mental Health Services Administration, Rockville, MD.
15. Corsi K.F., Kwiatkowski C.F., Booth R.E. Treatment entry and predictors among opiate-using injection drug users. Am. J. Drug Alcohol Abuse 2007, 33(1):121-127.
16. Deck D., Carlson M.J. Retention in publicly funded methadone maintenance treatment in two western states. J. Behav. Health Serv. Res. 2005, 32(1):43-60.
17. Griffith J.D., Knight D.K., Joe G.W., Simpson D.D. Implications of family and peer relations for treatment engagement and follow-up outcomes: an integrative model. Psychol. Addict. Behav. 1998, 21(2):113-126.
18. Gryczynski, J., Kinlock, T.W., Kelly, S.M., O'Grady, K.E., Gordon, M.S., Schwartz, R. P., in press. Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime. Subst. Abuse.
19. Gunderson E.W., Fiellin D.A. Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?. CNS Drugs 2008, 22(2):99-111.
20. Gyarmathy V.A., Latkin C.A. Individual and social factors associated with participation in treatment programs for drug users. Subst. Use Misuse 2008, 43(12-13):1865-1881.
21. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment?. J. Subst. Abuse Treat. 1998, 15(3):183-191.
22. Hendriks V.M., Kaplan C.D., van Limbeek J., Geerlings P. The addiction severity index: reliability and validity in a Dutch addict population. J. Subst. Abuse Treat. 1989, 6(2):133-141.
23. Hser Y.I., Maglione M., Polinsky M.L., Anglin M.D. Predicting drug treatment entry among treatment-seeking individuals. J. Subst. Abuse Treat. 1998, 15(3):213-220.
24. Joe G.W., Knezek L., Watson D., Simpson D.D. Depression and decision-making among intravenous drug users. Psychol. Rep. 1991, 68(1):339-347.
25. Kelly S.M., O'Grady K.E., Schwartz R.P., Peterson J.A., Wilson M.E., Brown B.S. The relationship of social support to treatment entry and engagement: the Community Assessment Inventory. Subst. Abuse 2010, 31(1):43-52.
26. Kleber H.D. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA 2008, 300(19):2303-2305.
27. Knight K., Holcum M., Simpson D.D. TCU Psychosocial Functioning and Motivation Scales: Manual on Psychometric Properties 1994, Institute of Behavorial Research, Texas Christian University, Fort Worth, Texas.
28. Kosten T.R., Rounsaville B.J., Kleber H.D. Concurrent validity of the addiction severity index. J. Nerv. Ment. Dis. 1983, 171(10):606-610.
29. Lloyd J.J., Ricketts E.P., Strathdee S.A. Social contextual factors associated with entry into opiate agonist treatment among injection drug users. Am. J. Drug Alcohol Abuse 2005, 31(4):555-570.
30. Madras B.K., Compton W.M., Avula D., Stegbauer T., Stein J.B., Clark H.W. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009, 99(1-3):280-295.
31. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 2009, 3. CD002209.
32. McLellan A.T., Luborsky L., Cacciola J. New data from the Addiction Severity Index. Reliability and validity in three centers. J. Nerv. Ment. Dis. 1985, 173(7):412-423.
33. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J. Nerv. Ment. Dis. 1980, 168(1):26-33.
34. Metzger D.S., Woody G.E., McLellan A.T. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 1993, 6(9):1049-1056.
35. Neufeld K., King V., Peirce J., Kolodner K., Brooner R., Kidorf M. A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals. Drug Alcohol Depend. 2008, 97(1-2):122-129.
36. Newman R.G., Bashkow S., Cates M. Arrest Histories Before and After Admission to a Methadone Maintenance Treatment Program. Contemporary Drug Problems 1973, Federal Legal Publications, New York.
37. Nurco, D.N., Wegner, N., Baum, H., Makotsky, A., 1979. A case study. Narcotic addiction over a quarter of a century in a major American city 1950-1977. Publication number (ADM) 80-937. National Institute on Drug Abuse Services Research Report, US Department of Health, Education and Welfare, Alcohol, Drug Abuse and Mental Health Administration.
38. Nurco D.N. A long-term program of research on drug use and crime. Subst. Use Misuse 1998, 33(9):1817-1837.
39. Nurco D.N., Hanlon T.E., Kinlock T.W., Duszynski K.R. Differential criminal patterns of narcotic addicts over an addiction career. Criminology 1988, 26:407-423.
40. O'Brien C., Cornish J.W. Naltrexone for probationers and parolees. J. Subst. Abuse Treat. 2006, 31(2):107-111.
41. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kellogg S., Satterfield F., Schwartz M., Krasnansky J., Pencer E., Silva-Vazquez L., Kirby K.C., Royer-Malvestuto C., Roll J.M., Cohen A., Copersino M.L., Kolodner K., Li R. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch. Gen. Psychiatry 2006, 63(2):201-208.
42. Peterson J.A., Reisinger H.S., Schwartz R.P., Mitchell S.G., Kelly S.M., Brown B.S., Agar M.H. Targeted sampling in drug abuse research: a review and case study. Field Methods 2008, 20(2):155-170.
43. Riley E.D., Safaeian M., Strathdee S.A., Brooner R.K., Beilenson P., Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst. Use Misuse 2002, 37(14):1869-1886.
44. Schütz C.G., Rapiti E., Vlahov D., Anthony J.C. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994, 36(2):129-138.
45. Schwartz R.P., Jaffe J.H., O'Grady K.E. Interim methadone treatment: impact on arrests. Drug Alcohol Depend. 2009, 103(3):148-154.
46. Schwartz R.P., Kelly S.M., O'Grady K.E., Mitchell S.G., Peterson J.A., Reisinger H.S., Agar M.H., Brown B.S. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am. J. Addict. 2008, 17(5):396-401.
47. Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., Strathdee S.A. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000, 14(13):2035-2043.
48. Simpson D.D. TCU Forms Manual: Drug Abuse Treatment for AIDS-Risk Reduction (DATAR) 1992, Texas Christian University, Forth Worth, Texas.
49. Simpson D.D., Dansereau D.F., Joe G.W. The DATAR project: cognitive and behavioral enhancements to community-based treatments. The Effectiveness of Innovative Strategies in the Treatment of Drug Abuse 1997, 182-203. Greenwood Press, Westport, CT. F.M. Tims, J.A. Inciardi, B.W. Fletcher, J.A.M. Horton (Eds.).
50. Simpson D.D., Joe G.W. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993, 30(2):357-367.
51. Simpson D.D., Joe G.W., Greener J.M., Rowan-Szal G.A. Modeling year 1 outcomes with treatment process and post treatment social influences. Subst. Use Misuse 2000, 35(12-14):1911-1930.
52. Simpson D.D., Knight K., Ray S. Psychosocial correlates of AIDS-risk drug use and sexual behaviors. AIDS Educ. Prev. 1993, 5(2):121-130.
53. Substance Abuse and Mental Health Services Administration, 2006. Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194). Rockville, MD.
54. Wilson M.E., Schwartz R.P., O'Grady K.E., Jaffe J.H. Impact of interim methadone maintenance on HIV risk behaviors. J. Urban Health 2010, 87(4):586-591.
55. Woody G.E., Munoz A. Efficacy, individual effectiveness, and population effectiveness in substance abuse treatment. Curr. Psychiatry Rep. 2000, 2(6):505-507.
56. Zanis D.A., Woody G.E. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend. 1998, 52(3):257-260.
57. Zule W.A., Desmond D.P. Factors predicting entry of injecting drug users into substance abuse treatment. Am. J. Drug Alcohol Abuse 2000, 26(2):247-261.